COVID-19 Vaccines and COVID-19 in People Living with HIV
Open Access
- 28 June 2024
- journal article
- research article
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (2) , 78-82
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a strain of the coronavirus that causes COVID-19, spread rapidly around the world and was defined as a pandemic on March 12, 2020, by the World Health Organization. As of June 2023, more than 767 million cases were confirmed globally, along with 6.9 million deaths.Keywords
This publication has 15 references indexed in Scilit:
- Covid-19 vaccine immunogenicity in people living with HIV-1Vaccine, 2022
- Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysisBMJ, 2022
- Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysisAIDS Research and Therapy, 2022
- Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative reviewClinical Microbiology and Infection, 2021
- HIV and SARS-CoV-2 Co-Infection: What are the Risks?Infection and Drug Resistance, 2021
- Impact of vaccination on new SARS-CoV-2 infections in the United KingdomNature Medicine, 2021
- COVID-19 and HIV infection co-pandemics and their impact: a review of the literatureAIDS Research and Therapy, 2021
- Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohortThe Lancet HIV, 2020
- HIV/SARS‐CoV‐2 coinfection: A global perspectiveJournal of Medical Virology, 2020
- Maintaining HIV care during the COVID-19 pandemicThe Lancet HIV, 2020